Kimberly-Clark de Mexico SAB de CV (OTCMKTS:KCDMY – Get Free Report) issued its quarterly earnings results on Tuesday. The basic materials company reported $0.20 earnings per share for the quarter, hitting the consensus estimate of $0.20, Zacks reports. The firm had revenue of $830.35 million during the quarter, compared to the consensus estimate of $839.55 million. Kimberly-Clark de Mexico SAB de CV had a return on equity of 164.99% and a net margin of 13.92%.
Kimberly-Clark de Mexico SAB de CV Trading Down 0.7%
OTCMKTS KCDMY traded down $0.07 during trading hours on Thursday, hitting $11.12. 4,527 shares of the company’s stock were exchanged, compared to its average volume of 49,659. The business’s 50 day moving average is $10.98 and its 200-day moving average is $11.44. The company has a debt-to-equity ratio of 11.44, a quick ratio of 1.36 and a current ratio of 1.55. Kimberly-Clark de Mexico SAB de CV has a 12-month low of $8.25 and a 12-month high of $12.84. The firm has a market capitalization of $6.84 billion, a P/E ratio of 15.88 and a beta of 0.67.
Wall Street Analyst Weigh In
Separately, HSBC cut Kimberly-Clark de Mexico SAB de CV from a “buy” rating to a “hold” rating in a report on Wednesday, April 29th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold”.
Kimberly-Clark de Mexico SAB de CV Company Profile
Kimberly-Clark de México, SAB. de C.V. operates as one of the leading manufacturers of personal care and paper‐based products in Mexico. As a locally managed subsidiary of the global Kimberly-Clark Corporation, the company focuses on the production, marketing and distribution of consumer staples designed for everyday use, ranging from facial and bathroom tissue to diapers and feminine care items.
The company’s portfolio includes well-known brands such as Kleenex and Scott for tissue products, Huggies for baby care, Kotex for feminine hygiene and Depend for adult incontinence.
Featured Articles
- Five stocks we like better than Kimberly-Clark de Mexico SAB de CV
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
- Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
Receive News & Ratings for Kimberly-Clark de Mexico SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark de Mexico SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.
